Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
2seventy bio's operating cash flow per share for the
three
months ended in Mar. 2025 was MXN-4.20.
2seventy bio's operating cash flow per share for the trailing twelve months (TTM) ended in Mar. 2025 was MXN-19.64.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the OCF Growth Rate using Operating Cash Flow per Share data.
The historical rank and industry rank for 2seventy bio's Operating Cash Flow per Share or its related term are showing as below:
MEX:TSVT's 3-Year OCF Growth Rate is not ranked *
in the Biotechnology industry.
Industry Median: 16.9 * Ranked among companies with meaningful 3-Year OCF Growth Rate only.
2seventy bio Operating Cash Flow per Share Related Terms
2seventy bio Operating Cash Flow per Share Historical Data
* Premium members only.
The historical data trend for 2seventy bio's Operating Cash Flow per Share can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
MEX:TSVT vs ALMS, TERN, CRVS: Operating Cash Flow per Share Comparison
For the Biotechnology subindustry, 2seventy bio's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
2seventy bio Price-to-Operating-Cash-Flow vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, 2seventy bio's Price-to-Operating-Cash-Flow distribution charts can be found below:
* The bar in red indicates where 2seventy bio's Price-to-Operating-Cash-Flow falls into.
Operating Cash Flow per Share for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was MXN-19.64
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a Operating Cash Flow per Share of MXN-19.64 mean?
2seventy bio (MEX:TSVT) has a Operating Cash Flow per Share of MXN-19.64 as of Mar. 2025. Operating cash flow per share equals the per-share amount of cash flow from operations. View historical data on 2seventy bio and its competitors.
Is 2seventy bio's Operating Cash Flow per Share too high?
2seventy bio's current Operating Cash Flow per Share is MXN-19.64. Overall, 2seventy bio has a GF Score™ of 9/100, reflecting its overall financial health beyond just this single metric.
How does 2seventy bio's Operating Cash Flow per Share compare to ALMS and TERN?
2seventy bio's Operating Cash Flow per Share of MXN-19.64 can be compared against companies in the Biotechnology industry. The industry median Operating Cash Flow per Share is 16.90. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Operating Cash Flow per Share for a Biotechnology company?
The median Operating Cash Flow per Share among Biotechnology companies is 16.90, based on 1,131 companies in the industry. Companies in the top quartile (top 25%) have a Operating Cash Flow per Share significantly above this median, while those in the bottom quartile fall well below. However, Operating Cash Flow per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Operating Cash Flow per Share mean?
A high Operating Cash Flow per Share can signal that a stock is expensive relative to its fundamentals. Operating cash flow per share equals the per-share amount of cash flow from operations. View historical data on 2seventy bio and its competitors. For the Biotechnology industry, the median Operating Cash Flow per Share is 16.90 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. 2seventy bio's current Operating Cash Flow per Share is MXN-19.64. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is 2seventy bio stock overvalued right now?
2seventy bio (MEX:TSVT) has a current Operating Cash Flow per Share of MXN-19.64. The current Operating Cash Flow per Share is MXN-19.64. 2seventy bio's overall GF Score™ is 9/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Operating Cash Flow per Share calculated?
Operating Cash Flow per Share is calculated from a company's financial statements. For 2seventy bio (MEX:TSVT), the current Operating Cash Flow per Share is MXN-19.64 as of Mar. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
2seventy bio Inc is a cell and gene therapy company focused on the research, development, and commercialization of transformative treatments for cancer. The company operates in a single segment focusing on researching, developing and commercializing potentially transformative treatments for cancer.
9GF Score
Get the complete analysis for MEX:TSVT
Operating Cash Flow per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MEX:TSVT has been successfully added to your 
